← FDA DRUG APPROVALS

FDA ANDA · ANDA088602

CORPHED

Sponsor: CHARTWELL RX

APPLICATION
ANDA088602
TYPE
ANDA
ORIGINAL APPROVAL
1985-04-11
LATEST ACTION
2001-05-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CORPHEDDiscontinued
PSEUDOEPHEDRINE HYDROCHLORIDE 60MG, TRIPROLIDINE HYDROCHLORIDE 2.5MG · TABLET · ORAL

Approval history

2001-05-09Manufacturing (CMC) · Supplement 6AP
1999-12-23Manufacturing (CMC) · Supplement 5AP
1994-01-24Manufacturing (CMC) · Supplement 4AP
1987-07-14Manufacturing (CMC) · Supplement 3AP
1987-07-14Manufacturing (CMC) · Supplement 2AP
1985-04-11OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →